Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126667621 | 12666762 | 1 | I | 20140527 | 20160808 | 20160819 | 20160819 | EXP | US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-01598 | WESTWARD | 33.00 | YR | M | Y | 0.00000 | 20160818 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126667621 | 12666762 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 84610 | QOW | ||||||||||
| 126667621 | 12666762 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 84610 | |||||||||||
| 126667621 | 12666762 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 84610 | QOD | ||||||||||
| 126667621 | 12666762 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 84610 | 10 | MG | |||||||||
| 126667621 | 12666762 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 84610 | |||||||||||
| 126667621 | 12666762 | 6 | SS | MERCAPTOPURINE. | MERCAPTOPURINE | 1 | Unknown | 40528 | |||||||||||
| 126667621 | 12666762 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 80352 | |||||||||||
| 126667621 | 12666762 | 8 | SS | HYDROMORPHONE | HYDROMORPHONE | 1 | Unknown | 74597 | |||||||||||
| 126667621 | 12666762 | 9 | SS | HYDROMORPHONE | HYDROMORPHONE | 1 | Oral | 74597 | |||||||||||
| 126667621 | 12666762 | 10 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 203856 | |||||||||||
| 126667621 | 12666762 | 11 | SS | CYTARABINE. | CYTARABINE | 1 | Unknown | 71471 | |||||||||||
| 126667621 | 12666762 | 12 | SS | CYTARABINE. | CYTARABINE | 1 | Intrathecal | 71471 | |||||||||||
| 126667621 | 12666762 | 13 | SS | CYTARABINE. | CYTARABINE | 1 | Intrathecal | 71471 | |||||||||||
| 126667621 | 12666762 | 14 | SS | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 80600 | |||||||||||
| 126667621 | 12666762 | 15 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | 0 | |||||||||||
| 126667621 | 12666762 | 16 | SS | PEG-ASPARGINASE | PEGASPARGASE | 1 | Unknown | 0 | |||||||||||
| 126667621 | 12666762 | 17 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | 0 | |||||||||||
| 126667621 | 12666762 | 18 | SS | MARQIBO | VINCRISTINE SULFATE | 1 | Unknown | 0 | |||||||||||
| 126667621 | 12666762 | 19 | SS | METHOTREXATE. | METHOTREXATE | 1 | Intrathecal | 0 | |||||||||||
| 126667621 | 12666762 | 20 | SS | METHOTREXATE. | METHOTREXATE | 1 | Intrathecal | 0 | |||||||||||
| 126667621 | 12666762 | 21 | SS | METHOTREXATE. | METHOTREXATE | 1 | Intrathecal | 0 | |||||||||||
| 126667621 | 12666762 | 22 | C | BLINATUMOMAB | BLINATUMOMAB | 1 | Unknown | 0 | |||||||||||
| 126667621 | 12666762 | 23 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Intrathecal | 0 | |||||||||||
| 126667621 | 12666762 | 24 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Intrathecal | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126667621 | 12666762 | 1 | Product used for unknown indication |
| 126667621 | 12666762 | 6 | Acute lymphocytic leukaemia |
| 126667621 | 12666762 | 7 | Acute lymphocytic leukaemia |
| 126667621 | 12666762 | 8 | Back pain |
| 126667621 | 12666762 | 10 | Product used for unknown indication |
| 126667621 | 12666762 | 11 | Product used for unknown indication |
| 126667621 | 12666762 | 12 | Central nervous system leukaemia |
| 126667621 | 12666762 | 14 | Anaemia |
| 126667621 | 12666762 | 15 | Acute lymphocytic leukaemia |
| 126667621 | 12666762 | 16 | Acute lymphocytic leukaemia |
| 126667621 | 12666762 | 17 | Acute lymphocytic leukaemia |
| 126667621 | 12666762 | 18 | Acute lymphocytic leukaemia |
| 126667621 | 12666762 | 19 | Leukaemia recurrent |
| 126667621 | 12666762 | 20 | Lumbar puncture |
| 126667621 | 12666762 | 22 | Bone pain |
| 126667621 | 12666762 | 23 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126667621 | 12666762 | HO |
| 126667621 | 12666762 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126667621 | 12666762 | Deep vein thrombosis | |
| 126667621 | 12666762 | Drug effect decreased | |
| 126667621 | 12666762 | Metapneumovirus infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126667621 | 12666762 | 1 | 20140214 | 0 | ||
| 126667621 | 12666762 | 2 | 2016 | 0 | ||
| 126667621 | 12666762 | 3 | 2016 | 0 | ||
| 126667621 | 12666762 | 4 | 201606 | 0 | ||
| 126667621 | 12666762 | 5 | 201607 | 0 | ||
| 126667621 | 12666762 | 6 | 2013 | 0 | ||
| 126667621 | 12666762 | 7 | 2013 | 0 | ||
| 126667621 | 12666762 | 8 | 20160530 | 0 | ||
| 126667621 | 12666762 | 10 | 2016 | 0 | ||
| 126667621 | 12666762 | 11 | 201603 | 0 | ||
| 126667621 | 12666762 | 12 | 20160602 | 0 | ||
| 126667621 | 12666762 | 13 | 20160606 | 0 | ||
| 126667621 | 12666762 | 15 | 2013 | 0 | ||
| 126667621 | 12666762 | 18 | 20140214 | 0 | ||
| 126667621 | 12666762 | 20 | 20160602 | 0 | ||
| 126667621 | 12666762 | 21 | 20160606 | 0 | ||
| 126667621 | 12666762 | 23 | 20160602 | 0 | ||
| 126667621 | 12666762 | 24 | 20160606 | 0 |